Selected research
Market Outlook & Growth Opportunities
Global TIGLUTIK Market Outlook and Growth Opportunities 2026
Market perspective
The global TIGLUTIK market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for TIGLUTIK is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for TIGLUTIK is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for TIGLUTIK is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the TIGLUTIK market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the TIGLUTIK market include Sun Pharma, Sanofi, Mylan Pharma, Lunan Pharma, Italfarmaco, Glemark Generics, Covis Pharma and Apotex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global TIGLUTIK market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of TIGLUTIK and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents TIGLUTIK sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the TIGLUTIK market size, projected growth trends, production technologies, key applications, and end-use industries.
TIGLUTIK Segment by Company
Sun Pharma
Sanofi
Mylan Pharma
Lunan Pharma
Italfarmaco
Glemark Generics
Covis Pharma
Apotex
TIGLUTIK Segment by Type
With Film-coated
Without Film-coated
TIGLUTIK Segment by Application
Hospital
Pharmacy
TIGLUTIK Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global TIGLUTIK status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions TIGLUTIK market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify TIGLUTIK significant trends, drivers, influence factors in global and regions.
6. To analyze TIGLUTIK competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TIGLUTIK market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of TIGLUTIK and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TIGLUTIK.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the TIGLUTIK market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global TIGLUTIK industry.
Chapter 3: Detailed analysis of TIGLUTIK manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of TIGLUTIK in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of TIGLUTIK in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- With Film-coated
- Without Film-coated
Applications
- Hospital
- Pharmacy
Companies covered
- Sun Pharma
- Sanofi
- Mylan Pharma
- Lunan Pharma
- Italfarmaco
- Glemark Generics
- Covis Pharma
- Apotex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global TIGLUTIK Sales Value (2021-2032)
- 1.2.2 Global TIGLUTIK Sales Volume (2021-2032)
- 1.2.3 Global TIGLUTIK Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 TIGLUTIK Market Dynamics
- 2.1 TIGLUTIK Industry Trends
- 2.2 TIGLUTIK Industry Drivers
- 2.3 TIGLUTIK Industry Opportunities and Challenges
- 2.4 TIGLUTIK Industry Restraints
3 TIGLUTIK Market by Company
- 3.1 Global TIGLUTIK Company Revenue Ranking in 2025
- 3.2 Global TIGLUTIK Revenue by Company (2021-2026)
- 3.3 Global TIGLUTIK Sales Volume by Company (2021-2026)
- 3.4 Global TIGLUTIK Average Price by Company (2021-2026)
- 3.5 Global TIGLUTIK Company Ranking (2024-2026)
- 3.6 Global TIGLUTIK Company Manufacturing Base and Headquarters
- 3.7 Global TIGLUTIK Company Product Type and Application
- 3.8 Global TIGLUTIK Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global TIGLUTIK Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 TIGLUTIK Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 TIGLUTIK Market by Type
- 4.1 TIGLUTIK Type Introduction
- 4.1.1 With Film-coated
- 4.1.2 Without Film-coated
- 4.2 Global TIGLUTIK Sales Volume by Type
- 4.2.1 Global TIGLUTIK Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global TIGLUTIK Sales Volume by Type (2021-2032)
- 4.2.3 Global TIGLUTIK Sales Volume Share by Type (2021-2032)
- 4.3 Global TIGLUTIK Sales Value by Type
- 4.3.1 Global TIGLUTIK Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global TIGLUTIK Sales Value by Type (2021-2032)
- 4.3.3 Global TIGLUTIK Sales Value Share by Type (2021-2032)
5 TIGLUTIK Market by Application
- 5.1 TIGLUTIK Application Introduction
- 5.1.1 Hospital
- 5.1.2 Pharmacy
- 5.2 Global TIGLUTIK Sales Volume by Application
- 5.2.1 Global TIGLUTIK Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global TIGLUTIK Sales Volume by Application (2021-2032)
- 5.2.3 Global TIGLUTIK Sales Volume Share by Application (2021-2032)
- 5.3 Global TIGLUTIK Sales Value by Application
- 5.3.1 Global TIGLUTIK Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global TIGLUTIK Sales Value by Application (2021-2032)
- 5.3.3 Global TIGLUTIK Sales Value Share by Application (2021-2032)
6 TIGLUTIK Regional Sales and Value Analysis
- 6.1 Global TIGLUTIK Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global TIGLUTIK Sales by Region (2021-2032)
- 6.2.1 Global TIGLUTIK Sales by Region: 2021-2026
- 6.2.2 Global TIGLUTIK Sales by Region (2027-2032)
- 6.3 Global TIGLUTIK Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global TIGLUTIK Sales Value by Region (2021-2032)
- 6.4.1 Global TIGLUTIK Sales Value by Region: 2021-2026
- 6.4.2 Global TIGLUTIK Sales Value by Region (2027-2032)
- 6.5 Global TIGLUTIK Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America TIGLUTIK Sales Value (2021-2032)
- 6.6.2 North America TIGLUTIK Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe TIGLUTIK Sales Value (2021-2032)
- 6.7.2 Europe TIGLUTIK Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific TIGLUTIK Sales Value (2021-2032)
- 6.8.2 Asia-Pacific TIGLUTIK Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America TIGLUTIK Sales Value (2021-2032)
- 6.9.2 South America TIGLUTIK Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa TIGLUTIK Sales Value (2021-2032)
- 6.10.2 Middle East & Africa TIGLUTIK Sales Value Share by Country, 2025 VS 2032
7 TIGLUTIK Country-level Sales and Value Analysis
- 7.1 Global TIGLUTIK Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global TIGLUTIK Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global TIGLUTIK Sales by Country (2021-2032)
- 7.3.1 Global TIGLUTIK Sales by Country (2021-2026)
- 7.3.2 Global TIGLUTIK Sales by Country (2027-2032)
- 7.4 Global TIGLUTIK Sales Value by Country (2021-2032)
- 7.4.1 Global TIGLUTIK Sales Value by Country (2021-2026)
- 7.4.2 Global TIGLUTIK Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.5.2 USA TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.9.2 France TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.16.2 China TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.19.2 India TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran TIGLUTIK Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt TIGLUTIK Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt TIGLUTIK Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt TIGLUTIK Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Sun Pharma
- 8.1.1 Sun Pharma Company Information
- 8.1.2 Sun Pharma Business Overview
- 8.1.3 Sun Pharma TIGLUTIK Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Sun Pharma TIGLUTIK Product Portfolio
- 8.1.5 Sun Pharma Recent Developments
- 8.2 Sanofi
- 8.2.1 Sanofi Company Information
- 8.2.2 Sanofi Business Overview
- 8.2.3 Sanofi TIGLUTIK Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Sanofi TIGLUTIK Product Portfolio
- 8.2.5 Sanofi Recent Developments
- 8.3 Mylan Pharma
- 8.3.1 Mylan Pharma Company Information
- 8.3.2 Mylan Pharma Business Overview
- 8.3.3 Mylan Pharma TIGLUTIK Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Mylan Pharma TIGLUTIK Product Portfolio
- 8.3.5 Mylan Pharma Recent Developments
- 8.4 Lunan Pharma
- 8.4.1 Lunan Pharma Company Information
- 8.4.2 Lunan Pharma Business Overview
- 8.4.3 Lunan Pharma TIGLUTIK Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Lunan Pharma TIGLUTIK Product Portfolio
- 8.4.5 Lunan Pharma Recent Developments
- 8.5 Italfarmaco
- 8.5.1 Italfarmaco Company Information
- 8.5.2 Italfarmaco Business Overview
- 8.5.3 Italfarmaco TIGLUTIK Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Italfarmaco TIGLUTIK Product Portfolio
- 8.5.5 Italfarmaco Recent Developments
- 8.6 Glemark Generics
- 8.6.1 Glemark Generics Company Information
- 8.6.2 Glemark Generics Business Overview
- 8.6.3 Glemark Generics TIGLUTIK Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Glemark Generics TIGLUTIK Product Portfolio
- 8.6.5 Glemark Generics Recent Developments
- 8.7 Covis Pharma
- 8.7.1 Covis Pharma Company Information
- 8.7.2 Covis Pharma Business Overview
- 8.7.3 Covis Pharma TIGLUTIK Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Covis Pharma TIGLUTIK Product Portfolio
- 8.7.5 Covis Pharma Recent Developments
- 8.8 Apotex
- 8.8.1 Apotex Company Information
- 8.8.2 Apotex Business Overview
- 8.8.3 Apotex TIGLUTIK Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Apotex TIGLUTIK Product Portfolio
- 8.8.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 TIGLUTIK Value Chain Analysis
- 9.1.1 TIGLUTIK Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 TIGLUTIK Sales Mode & Process
- 9.2 TIGLUTIK Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 TIGLUTIK Distributors
- 9.2.3 TIGLUTIK Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst